Home
About Us
Introduction
Career Opportunites
Contact Details
Collaborations
News & Resources
News
News Archives
Resources
Newsletter
Literature
Case Studies
Blog
In Vitro Services
By Cell Type
By Assay Type
ImmuneProfiler
Biomarker Analysis
Gene Expression Analysis
Multiplex Testing Service
In Vivo Services
Inflammation Disease Models
General models of inflammation
Arthritis in-vivo inflammatory models
Allergic Asthma In-Vivo Model
Contact Dermatitis
Type I Diabetes
Inflammatory Bowel Disease (IBD) in-vivo model In
Neurology Disease Models
Multiple Sclerosis in-vivo model
Pain Models
Parkinson's Disease
Gliosis
Myocardial Ischemia Reperfusion
White Papers
Histology
Contact Us
Contact Us
Products
Posts by category
in vitro compound screening (1)
in vivo efficacy (8)
inflammation (4)
Mode of action (1)
Multiple Sclerosis (1)
Myocardial Infarct (1)
Neuroinflammation (1)
Pain (4)
Rheumatoid Arthritis (3)
Subscribe by Email
Your email:
Drug Discovery in Neuroinflammations
Current Articles
|
RSS Feed
Cutting Edge Readouts for Rheumatoid Arthritis Models (part 1)
Preclinical Occlusion-induced ischemia reperfusion injury model
Targeting fibroblast-like synovioctyes: preclinical screening assays.
Effiacy of anti-CD20 therapy in Rhuematoid Arthritis
Determine immunomodulatory mechanism of action for compounds
Parameters for evaluating neuroprotective treatments in EAE models
Why is post-operative pain under treated?
Pain Processing: Cation Channel Blockers. Choosing models of pain.
Cannabinoid System as a target for pain relief.
α2-adrenergic Agonists and Tricyclic Antidepressants Evaluating Compounds in Relevant Models of Pain
Error sending email
Email sent successfully
Email article
Email To :
Email From :
Message :